Organizers envisioned Widett Circle in Boston being redeveloped as a new neighborhood after the Games ended, similar to what’s pictured in the rendering above. The area was being pushed as a site for the Olympic  stadium.

Boston 2024

Organizers envisioned Widett Circle in Boston being redeveloped as a new neighborhood after the Games ended, similar to what’s pictured in the rendering above. The area was being pushed as a site for the Olympic stadium.

Can there be an Olympic legacy in Boston with no Olympics?

The Globe spoke with developers and owners of prospective Olympic sites in Boston about how the bid’s demise might affect their plans. By Jon Chesto and Callum Borchers

David Bookbinder saved $600 a year by switching to Allstate for his auto insurance.

Pricey car insurance policies test consumers

Even though insurance regulators and pro-athlete pitchmen urge consumers to compare prices, 1 in 3 policyholders have never shopped for insurance quotes.

Biogen seen vulnerable to takeover after sell-off

The Cambridge biotechnology giant now may have to make a bold move to reassure investors.

BetaBoston

//c.o0bg.com/rf/image_90x90/Boston/2011-2020/2015/06/16/BostonGlobe.com/Business/Images/90x90-Beta-Boston.png

Want to keep up with the news that matters from Boston’s innovators? Get coverage of apps, biotech, computing, data, and everything else.

Latest Business headlines

Steven Syre | Boston Capital

How a small drug maker enters the market to soaring stock prices

Last month’s widely popular IPO by XSeres Therapeutics Inc. of Cambridge was the culmination of hard work, successful clinical tests, and good timing.

Shirley Leung

No time to celebrate no Olympics in Boston

Given the chance to think big about our future, we tied ourselves up in the minutiae of tax breaks and traffic studies.

Snapshot: China’s fall ripples around globe

The worst drop in China’s stock market in eight years helped drag down other markets around the world Monday.

Ten things you may have missed Monday from the world of business

Genzyme to buy AstraZeneca’s thyroid cancer drug, Teva to pay $40.5b for Allergan’s generics unit, and more news from Monday.

Greece kicks off talks with creditors

Greece’s government on Monday launched complex bailout negotiations with its creditors.

Higher fees propel airlines’ profits -- and travelers’ ire

Even with a Department of Justice investigation into possible collusion among airlines, the penchant for fees is not going away any time soon.

Bold Types

Entrepreneurship center at Harvard gets a new chief

Jodi Gernon joins the Rock Center team from Launchitivity, a company she founded in 1999 that provides advice for consumer health care startups.

BetaBoston

Smart-home startup lands new investment

Ecovent Corp., a Boston startup that makes a “smart” heating vent system for homes, has landed a $6.9 million investment to help launch its product later this year.

Shirley Leung

Leung writes a business column every Wednesday and Friday. Previously she served six years as the business editor overseeing daily and Sunday coverage.